Literature DB >> 17164229

A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.

U Veronesi1, C De Cicco, V E Galimberti, J R Fernandez, N Rotmensz, G Viale, G Spano, A Luini, M Intra, P Veronesi, A Berrettini, G Paganelli.   

Abstract

BACKGROUND: Sentinel node biopsy (SNB) has become a standard treatment in staging axillary lymph nodes in early breast cancer. SNB, however, is an invasive procedure and is time-consuming when the sentinel node is analysed intra-operatively. Breast cancer is frequently characterised by increased 2-fluoro-2-deoxy-D-glucose uptake and many studies have shown encouraging results in detecting axillary lymph node metastases. The aim of this study was to compare SNB and -positron emission tomography (-PET) imaging, to assess their values in detecting occult axillary metastases. PATIENTS AND METHODS: In all, 236 patients with breast cancer and clinically negative axilla were enrolled in the study. 18-FDG-PET was carried out before surgery, using a positron emission tomography (PET)/computed tomography scanner. In all patients, SNB was carried out after identification through lymphoscintigraphy. Patients underwent axillary lymph nodes dissection (ALND) in cases of positive FDG-PET or positive SNB. The results of PET scan were compared with histopathology of SNB and ALND.
RESULTS: In all, 103 out of the 236 patients (44%) had metastases in axillary nodes. Sensitivity of FDG-PET scan for detection of axillary lymph node metastases in this series was low (37%); however, specificity and positive predictive values were acceptable (96% and 88%, respectively).
CONCLUSIONS: The high specificity of PET imaging indicates that patients who have a PET-positive axilla should have an ALND rather than an SNB for axillary staging. In contrast, FDG-PET showed poor sensitivity in the detection of axillary metastases, confirming the need for SNB in cases where PET is negative in the axilla.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17164229     DOI: 10.1093/annonc/mdl425

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  39 in total

1.  Investigation of 18F-FDG PET in the selection of patients with breast cancer as candidates for sentinel node biopsy after neoadjuvant therapy.

Authors:  Laura Gilardi; Concetta De Cicco; Marco Colleoni; Anna Cardillo; Emilia Montagna; Silvia Dellapasqua; Viviana Galimberti; Vincenzo Bagnardi; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-10       Impact factor: 9.236

2.  Can FDG PET/CT monitor the response to hormonal therapy in breast cancer patients?

Authors:  Laura Evangelista; Domenico Rubello; Giorgio Saladini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03       Impact factor: 9.236

3.  [Non-invasive imaging modalities for preoperative axillary lymph node staging in patients with breast cancer].

Authors:  K Wasser; A Schnitzer; J Brade; S O Schoenberg
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

4.  Semiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant?

Authors:  Selin Carkaci; Beatriz E Adrada; Eric Rohren; Wei Wei; Mohammad A Quraishi; Osama Mawlawi; Thomas A Buchholz; Wei Yang
Journal:  Acad Radiol       Date:  2012-02-01       Impact factor: 3.173

Review 5.  Present and future role of FDG-PET/CT imaging in the management of breast cancer.

Authors:  Kazuhiro Kitajima; Yasuo Miyoshi
Journal:  Jpn J Radiol       Date:  2016-01-05       Impact factor: 2.374

Review 6.  Should FDG PET/CT be used for the initial staging of breast cancer?

Authors:  David Groheux; Elif Hindié; Domenico Rubello; Marc Espié; Georges Baillet; Sylvie Giacchetti; Jean-Louis Misset; Jean-Luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

7.  Novel navigation surgery using image fusion of PET/CT and sonography for axillary neoplasm: First experience.

Authors:  Manabu Futamura; Kasumi Morimitsu; Masahito Nawa; Masako Kanematsu; Naoe Gotoh; Kazuhiro Yoshida
Journal:  Int J Surg Case Rep       Date:  2013-06-06

8.  A different role for FDG PET/CT in axillary lymph node staging in breast cancer.

Authors:  Tjeerd S Aukema; Marieke E Straver; Renato A Valdés Olmos; Wouter V Vogel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-07-25       Impact factor: 9.236

9.  MR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates.

Authors:  Takahito Nakajima; Baris Turkbey; Kohei Sano; Kazuhide Sato; Marcelino Bernardo; Robert F Hoyt; Peter L Choyke; Hisataka Kobayashi
Journal:  J Magn Reson Imaging       Date:  2013-10-10       Impact factor: 4.813

Review 10.  Role of FDG PET-CT in evaluation of locoregional nodal disease for initial staging of breast cancer.

Authors:  Yiyan Liu
Journal:  World J Clin Oncol       Date:  2014-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.